Baseline characteristics of participants in the Biomarkers for Evaluating Spine Treatments clinical trial: a sequential multiple assignment randomized trial for chronic low back pain - Summary - MDSpire

Baseline characteristics of participants in the Biomarkers for Evaluating Spine Treatments clinical trial: a sequential multiple assignment randomized trial for chronic low back pain

  • By

  • Bryce Rowland

  • Kelly S Barth

  • Kevin M Bell

  • Amber K Brooks

  • Andrea L Chadwick

  • Annika Cleven

  • Robert W Hurley

  • Sean Mackey

  • Kushang V Patel

  • Sara R Piva

  • Michael J Schneider

  • Fatima Al-Kadhi

  • Bernice Asante-Nketiah

  • Sarah Bagaason

  • Anna Batorsky

  • Jeffrey J Borckardt

  • Anton E Bowden

  • Timothy S Carey

  • Joel Castellanos

  • Lucy Chen

  • Brooke Chidgey

  • Diane Dalton

  • Jonathan S Dufour

  • Jaclyn L Eberting

  • Seth M Eller

  • Aaron J Fields

  • Julie M Fritz

  • Amber Fu

  • Inam Ghulamhussain

  • Rachel West Goolsby

  • Carol M Greco

  • Sarah Grim

  • Cameron A Gunn

  • Lindsay Hanes

  • Richard E Harris

  • Steven E Harte

  • Afton L Hassett

  • Kinsey Helton

  • Anna Hoffmeyer

  • Anastasia Ivanova

  • Sara Jones Berkeley

  • Chelsea Kaplan

  • Kelley M Kidwell

  • Gregory G Knapik

  • Michael R Kosorok

  • Gregorij Kurillo

  • David Li

  • Remy Lobo

  • Joseph Long

  • Jeffrey C Lotz

  • Prasath Mageswaran

  • Sharmila Majumdar

  • Jianren Mao

  • William S Marras

  • Lance M McCracken

  • Micah McCumber

  • Samuel A McLean

  • Miranda McMillan

  • Wolf Mehling

  • Rafael Mendoza

  • Ulrike H Mitchell

  • Vitaly Napadow

  • Conor O'Neill

  • Sydnee Pearson

  • Scott Peltier

  • Sean D Rundell

  • Sonja Ryser

  • Andrew Schrepf

  • Emily Schulze

  • John Sperger

  • Nam Vo

  • Mark S Wallace

  • Abigail M Wampler

  • Ajay D Wasan

  • Tristan E Weaver

  • Kenneth A Weber

  • Lauren Wilcox

  • David A Williams

  • Leslie Wilson

  • Jacqueline E Woo

  • Fadel Zeidan

  • Beibo Zhao

  • Brianna Zhou

  • Kevin J Anstrom

  • Daniel J Clauw

  • Gwendolyn A Sowa

  • Matthew C Mauck

  • August 5, 2025

  • 0 min

Share

Objective:

Emphasize the urgency of adopting a precision medicine approach for cLBP.

Key Findings:
  • Add context on the significance of the demographic diversity.
Interpretation:

Mention implications for future research based on findings.

Limitations:
  • Expand on how biases might affect treatment efficacy.
Conclusion:

Reiterate the dataset's importance for future analyses.

Original Source(s)

Related Content